COLTENE Holding AG (SWX:CLTN)
Switzerland · Delayed Price · Currency is CHF 47.80
-0.20 (-0.42%)
Apr 2, 2026, 5:30 PM CET
COLTENE Holding AG Revenue
In the year 2025, COLTENE Holding AG had annual revenue of 240.05M CHF, down -4.04%. COLTENE Holding AG had revenue of 122.00M in the half year ending December 31, 2025, with 9.61% growth.
Revenue
240.05M
Revenue Growth
-4.04%
P/S Ratio
1.19
Revenue / Employee
203.43K
Employees
1,180
Market Cap
285.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 240.05M | -10.11M | -4.04% |
| Dec 31, 2024 | 250.16M | 7.43M | 3.06% |
| Dec 31, 2023 | 242.73M | -24.40M | -9.13% |
| Dec 31, 2022 | 267.13M | -12.12M | -4.34% |
| Dec 31, 2021 | 279.24M | 30.89M | 12.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| DocMorris AG | 1.12B |
| Ascom Holding AG | 292.10M |
| Basilea Pharmaceutica AG | 232.38M |
| IVF Hartmann Holding AG | 161.85M |
COLTENE Holding AG News
- 13 days ago - Coltene Holding AG (XSWX:CLTN) Full Year 2025 Earnings Call Highlights: Navigating Challenges ... - GuruFocus
- 13 days ago - Full Year 2025 Coltene Holding AG Earnings Call Transcript - GuruFocus